Our analyses of BM samples from 22 NDMM patients, 5 patients in complete remission(CR), and 9 healthy controls indicated that ACBD6 levels were markedly higher in the MM group compared to the control group. This evidence concerns the gene ACBD6 and Miyoshi myopathy.